Loading...

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Renal impairment is frequent in patients with multiple myeloma and is correlated with an inferior prognosis. This analysis evaluates the prognostic role of renal impairment in patients with myeloma treated with bortezomib before and after autologous stem cell transplantation within a prospective ran...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Scheid, Christof, Sonneveld, Pieter, Schmidt-Wolf, Ingo G.H., van der Holt, Bronno, el Jarari, Laila, Bertsch, Uta, Salwender, Hans, Zweegman, Sonja, Blau, Igor Wolfgang, Vellenga, Edo, Weisel, Katja, Pfreundschuh, Michael, Jie, Kon-Siong, Neben, Kai, van de Velde, Helgi, Duehrsen, Ulrich, Schaafsma, M. Ron, Lindemann, Walter, Kersten, Marie José, Peter, Norma, Hänel, Mathias, Croockewit, Sandra, Martin, Hans, Wittebol, Shulamiet, Bos, Gerard MJ, van Marwijk-Kooy, Marinus, Wijermans, Pierre, Goldschmidt, Hartmut, Lokhorst, Henk M.
Format: Artigo
Sprog:Inglês
Udgivet: Ferrata Storti Foundation 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007933/
https://ncbi.nlm.nih.gov/pubmed/23996482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.087585
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!